Physician

Suresh Devineni, M.D.

According to 2025 Medicare claims, Suresh Devineni, M.D. (NPI: 1033301858) practices hematology/oncology in the Mankato, MN market, with the plurality of this provider's patient population coming from Blue Earth, MN. This provider's primary affiliated billing organization is MANKATO CLINIC LTD (NPI: 1629044029; TIN: 410849339) and primary practice location at 56001-5066. Devineni is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), Stratum Med ACO (ACO ID: A4527), Mayo Clinic Community ACO, LLC (ACO ID: A4617), Avera Prairie View ACO (ACO ID: A4692), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Devineni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 591 traditional Medicare patients, billed 194,627 HCPCS/CPT codes, and received $3,005,785 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,161 prescription claims across 324 beneficiaries totaling $5,616,763 in drug costs, led by Erleada (Apalutamide). DME data shows 63 claims. Open Payments data shows 6 records totaling $3,532. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $936,322 to $3,005,785. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,066,162 to $5,616,763. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,195 to $3,212.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	369	84,285	$936,322
2016	359	134,494	$1,651,228
2017	362	124,490	$1,521,470
2018	386	109,160	$1,739,351
2019	661	225,836	$3,195,952
2020	594	210,837	$2,972,984
2021	634	198,052	$3,559,586
2022	641	206,985	$3,145,176
2023	611	243,836	$3,118,021
2024	591	194,627	$3,005,785

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	183	1,282	$1,066,162
2016	203	1,467	$1,127,166
2017	206	1,460	$1,302,512
2018	224	1,336	$1,247,197
2019	230	1,470	$1,814,679
2020	240	1,662	$2,007,609
2021	264	1,769	$2,923,942
2022	271	1,829	$3,646,315
2023	307	2,054	$5,639,525
2024	324	2,161	$5,616,763

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$17,406
2016	N/R	22	$519
2017	N/R	12	$171
2018	N/R	24	$248
2019	N/R	52	$6,158
2020	N/R	57	$5,798
2021	N/R	31	$1,859
2022	N/R	58	$1,833
2023	N/R	77	$14,385
2024	N/R	63	$1,757

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	226	571	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	187	229	$11
80053	Blood test, comprehensive group of blood chemicals	381	997	$10
36415	Insertion of needle into vein for collection of blood sample	397	1,084	$9
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	274	545	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	106	3,570	$1,373,971
Xtandi	Enzalutamide	77	2,220	$828,139
Ibrance	Palbociclib	43	1,204	$727,563
Imbruvica	Ibrutinib	30	852	$558,516
Pomalyst	Pomalidomide	13	364	$290,145

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	19	$834
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	31	$583
J8530	Cyclophosphamide; oral, 25 mg	N	N/R	13	$339

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$3,532	BeiGene USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Suresh Devineni, M.D.?

Tedicare shows public-source Medicare data for Suresh Devineni, M.D. (NPI 1033301858), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Suresh Devineni, M.D. have ACO affiliation data?

Suresh Devineni, M.D. is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844), Stratum Med ACO (MSSP, ACO ID A4527), Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617), Avera Prairie View ACO (MSSP, ACO ID A4692), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Suresh Devineni, M.D.?

Suresh Devineni, M.D. is linked to MANKATO CLINIC LTD (billing NPI 1629044029) in the available physician profile data.

Does Suresh Devineni, M.D. have Open Payments data?

Suresh Devineni, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.